Browsing Tag
Oncology
318 posts
Halozyme Therapeutics to acquire specialty pharma company Antares Pharma for $960m
Halozyme Therapeutics, a California-based publicly-listed biotech company, has agreed to acquire New Jersey-based specialty pharma company Antares Pharma…
Adagene, Sanofi signs collaboration and license deal worth up to $2.5bn
Adagene, a US-based biopharma company, has signed a collaboration and license deal worth up to $2.5 billion plus…
Zai Lab treats first patient in China in PANOVA-3 trial of TTFields
Zai Lab Limited said that it has treated the first patient in Greater China in the PANOVA-3 phase…
Alphamab Oncology enrols patients for KN026-203 phase 2 clinical trial
Alphamab Oncology said that it has completed enrolling patients in China for its KN026-203 phase 2 clinical trial…
Labcorp to acquire Personal Genome Diagnostics in $575m worth deal
Labcorp, a North Carolina-based life sciences company, has agreed to acquire Personal Genome Diagnostics (PGDx), a provider of…
Sun Pharma Advanced Research signs licensing deal with Biomodifying
Sun Pharma Advanced Research Company (SPARC) has signed an agreement with US-based Biomodifying for the exclusive licensing of…
Lupin enters Brazilian oncology biosimilars market with Biomm deal for Pegfilgrastim
Lupin partners with Biomm SA to bring biosimilar Pegfilgrastim to Brazil, expanding oncology supportive care access and entering Latin America’s biologics market.
Zydus Cadila gets FDA final approval for Decitabine injection
Zydus Cadila has secured final approval from the US Food and Drug Administration (FDA) for the commercialization of…
Natco Pharma launches PrNAT-LENALIDOMIDE Capsules in Canada
Natco Pharma Limited has announced the Canadian launch of PrNAT-LENALIDOMIDE Capsules, a generic version of Celgene Corporation’s cancer…
DESTINY-Gastric02 phase 2 trial results : Enhertu shows clinically meaningful and durable tumor response
AstraZeneca said that Enhertu (trastuzumab deruxtecan) has shown clinically meaningful and durable response in the DESTINY-Gastric02 phase 2…